133 related articles for article (PubMed ID: 12930158)
1. DNA methylation patterns in cancer: novel prognostic indicators?
Frühwald MC
Am J Pharmacogenomics; 2003; 3(4):245-60. PubMed ID: 12930158
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
[TBL] [Abstract][Full Text] [Related]
3. Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes.
Aoki E; Uchida T; Ohashi H; Nagai H; Murase T; Ichikawa A; Yamao K; Hotta T; Kinoshita T; Saito H; Murate T
Leukemia; 2000 Apr; 14(4):586-93. PubMed ID: 10764143
[TBL] [Abstract][Full Text] [Related]
4. Glyco-genes change expression in cancer through aberrant methylation.
Vojta A; Samaržija I; Bočkor L; Zoldoš V
Biochim Biophys Acta; 2016 Aug; 1860(8):1776-85. PubMed ID: 26794090
[TBL] [Abstract][Full Text] [Related]
5. Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential.
Frühwald MC; Plass C
Mol Genet Metab; 2002 Jan; 75(1):1-16. PubMed ID: 11825059
[TBL] [Abstract][Full Text] [Related]
6. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
Liu Z; Wang LE; Wang L; Lu KH; Mills GB; Bondy ML; Wei Q
Clin Cancer Res; 2005 Jul; 11(13):4968-76. PubMed ID: 16000597
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation, chromatin inheritance, and cancer.
Rountree MR; Bachman KE; Herman JG; Baylin SB
Oncogene; 2001 May; 20(24):3156-65. PubMed ID: 11420732
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
9. Alterations of DNA methylation in hematologic malignancies.
Rush LJ; Plass C
Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
[TBL] [Abstract][Full Text] [Related]
10. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
11. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
Esteller M; Herman JG
J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635
[TBL] [Abstract][Full Text] [Related]
12. [DNA methylation: potential for diagnosis, prognosis and therapy--prediction in oncology].
Haedicke W; Lesche R
Verh Dtsch Ges Pathol; 2006; 90():39-45. PubMed ID: 17867578
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Methylation in Colorectal Cancer.
Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
[TBL] [Abstract][Full Text] [Related]
14. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic diagnostics of cancer--the application of DNA methylation markers.
Paluszczak J; Baer-Dubowska W
J Appl Genet; 2006; 47(4):365-75. PubMed ID: 17132902
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB
Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182
[TBL] [Abstract][Full Text] [Related]
18. Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.
Dai W; Cheung AK; Ko JM; Cheng Y; Zheng H; Ngan RK; Ng WT; Lee AW; Yau CC; Lee VH; Lung ML
Cancer Med; 2015 Jul; 4(7):1079-90. PubMed ID: 25924914
[TBL] [Abstract][Full Text] [Related]
19. [Dynamics of LINE-1 Retrotransposon Methylation Levels in Circulating DNA from Lung Cancer Patients Undergoing Antitumor Therapy].
Ponomaryova AA; Cherdyntseva NV; Bondar AA; Dobrodeev AY; Zavyalov AA; Tuzikov SA; Vlassov VV; Choinzonov EL; Laktionov PP; Rykova EY
Mol Biol (Mosk); 2017; 51(4):622-628. PubMed ID: 28900080
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation patterns in cancer: a clinical view.
Paska AV; Hudler P
Biochem Med (Zagreb); 2015; 25(2):161-76. PubMed ID: 26110029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
